KAPA
KAIROS PHARMA (KAPA)
NYSE
$0.47+$0.007 (+1.43%)
Price as of Jun 03, 2026 7:28 PM EDT
  • $10.9M
    Market Cap
  • -11.18%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-2.1M
+415.70%
-414,000
N/A
Depreciation and Amortization Expense
160,000
+158.06%
62,000
N/A
Total Operating Expenses
5.6M
+137.81%
2.3M
N/A
Operating Profit
-5.6M
+137.81%
-2.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
125,000
+148.08%
-260,000
N/A
Income before Taxes
-5.6M
+137.81%
-2.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
Basic EPS and Net Income
-0.30
+30.43%
-0.23
N/A
Diluted EPS and Net Income
-0.30
+30.43%
-0.23
N/A
Basic Weighted Average Shares
18.4M
+62.27%
11.4M
N/A
Diluted Weighted Average Shares
18.4M
+62.27%
11.4M
N/A
Balance Sheet
Cash and Cash Equivalents
4.5M
+253.07%
1.3M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.5M
+253.07%
1.3M
N/A
Total Current Assets
5.4M
+29.22%
4.2M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
1.2M
-27.89%
1.6M
N/A
Total Assets
6.5M
+13.38%
5.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
792,000
-63.49%
2.2M
N/A
Total Current Liabilities
199,000
-79.94%
992,000
N/A
Total Long-Term Debt
675,000
-23.73%
885,000
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
Total Liabilities
199,000
-79.94%
992,000
N/A
Retained Earnings
-14.3M
+61.79%
-8.8M
N/A
Total Stockholders Equity
6.3M
+32.77%
4.8M
N/A
Total Shares Outstanding
20.8M
+51.58%
13.7M
N/A
Cash Flow
Cash from Operating Activities
-3.4M
-13.00%
-4.0M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.7M
+29.72%
5.1M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
27.07
N/A
N/A
N/A
Cash Ratio
22.57
N/A
N/A
N/A
Debt-to-Equity Ratio
0.23
N/A
N/A
N/A
Debt-to-Assets Ratio
0.22
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow